Professional Profile
Mr. Ivar S. Jensen is Vice President and Principal of the BlueRidge Life Sciences Pharmaceutical Commercialization Practice. With over 20 years of experience in life science consulting, Mr. Jensen’s expertise lies in leading teams to develop robust, rigorous, and evidence-based solutions for pharmaceutical, biopharmaceutical, diagnostic, and medical device companies. He is experienced in constructing all types of health economic models, including cost-effectiveness, budget-impact, cost-consequence, cost-benefit, cost-calculators, net clinical benefit, and value demonstration tools, as well as epidemiology and revenue forecast models, and he is committed to partnering with clients to ensure their products demonstrate value and achieve successful market access. Mr. Jensen has broad therapeutic area expertise that includes cardiology, central nervous system, respiratory, oncology, hematology, organ transplant, immunology, infectious disease, ophthalmology, rare diseases, and gene therapies. He has supported clients in obtaining US Food and Drug Administration (FDA) priority review vouchers, and with health technology assessment (HTA) submissions and health economic models in the U.S. and internationally.
Mr. Jensen has authored or co-authored numerous manuscripts and over 50 abstracts and presentations. He serves as a peer reviewer for several publications and is fluent in Danish.